EPISODE · Jan 31, 2018 · 39 MIN
Update on Medical and Surgical Management of Advanced Testis Cancer
from AUAUniversity · host American Urological Association
Dr Nitti and Dr. Daneshmand discuss the AUA Update Series Article titled "Update on Medical and Surgical Management of Advanced Testis Cancer" This episode will describe and explain the current recommendations for imaging; indications for post-chemotherapy retroperitoneal lymph node dissection; the IGCCCG (International Germ Cell Cancer Consensus Group) risk classification; and pros and cons of 3 cycles of cisplatin, etoposide and bleomycin vs 4 cycles of etoposide and cisplatin EP for IGCCCG good risk disease.
What this episode covers
Dr Nitti and Dr. Daneshmand discuss the AUA Update Series Article titled "Update on Medical and Surgical Management of Advanced Testis Cancer" This episode will describe and explain the current recommendations for imaging; indications for post-chemotherapy retroperitoneal lymph node dissection; the IGCCCG (International Germ Cell Cancer Consensus Group) risk classification; and pros and cons of 3 cycles of cisplatin, etoposide and bleomycin vs 4 cycles of etoposide and cisplatin EP for IGCCCG good risk disease.
NOW PLAYING
Update on Medical and Surgical Management of Advanced Testis Cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.